|
Piperazine CitrateDrug - Piperazine Citrate The trade name of the product as shown on the labeling.
Dosage -
SYRUP; ORAL
Active Ingredient(s) -
Piperazine Citrate
Strength -
EQ 500MG BASE/5ML
Applicant -
LUITPOLD
New Drug Application (NDA) Number -
080671
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Luitpold Pharmaceuticals Inc
Piperazine Citrate
Multifuge Eq 500mg Base/5ml Syrup; Oral
Piperazine Citrate Eq 500mg Base/5ml Syrup; Oral Piperazine Citrate Eq 500mg Base/5ml Syrup; Oral Piperazine Citrate Eq 500mg Base/5ml Syrup; Oral Zosyn Eq 4gm Base/vial;eq 500mg Base/vial Injectable; Injection Zosyn In Plastic Container Eq 40mg Base/ml;eq 5mg Base/ml Injectable; Injection Zosyn In Plastic Container Eq 4gm Base/100ml;eq 500mg Base/100ml Injectable; Injection Zosyn In Plastic Container Eq 60mg Base/ml;eq 7.5mg Base/ml Injectable; Injection Antepar Eq 500mg Base/5ml Syrup; Oral Bryrel Eq 500mg Base/5ml Syrup; Oral NewDrugInformation |